Southern States Annual Meeting

Friday, February 7, 2014
6:00 - 7:00 p.m. Welcome Reception
Saturday, February 8, 2014
7:00 - 8:00 a.m. Continental Breakfast
8:00 - 8:15 a.m. Opening Remarks & Pre-Meeting Assessment
Objectives:
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:15 - 9:15 a.m. Thyroid Cancer
Bryan Haugen, MD
Objectives:
  1. Effectively risk-stratify patients with differentiated thyroid cancer regarding survival and recurrence risk.
  2. Identify those patients who would most-likely benefit from radioiodine treatment.
  3. Efficiently apply long-term monitoring strategies for patients with differentiated thyroid cancer.
9:15 - 10:15 a.m. New Paradigms That Increase Survival in Neuroendocrine Tumor Patients
Eugene A Woltering, MD, FACS
Objectives:
  1. Describe the role of Neurokinin A marker measurement in determining the prognosis of a mid gut carcinoid with Stage 4 disease.
  2. Describe the utility of measuring octreotide plasma level in patients receiving octreotide acetate by continuous pump infusion or LAR injections.
  3. Discuss the heterogeneity of primary tumor, nodal and metastatic tumors when stained for NET tumor markers.
10:15 - 10:45 a.m. Break
10:45 - 11:45 a.m. Anabolic, Antiresorptive & Emerging New Therapies for Osteoporosis
Nelson B. Watts, MD, FACP, MACE
Objectives:
  1. Explain the mechanisms of action of agents to treat osteoporosis.
  2. Become familiar with new data on approved therapeutic agents.
  3. Identify the agents currently in development for treatment of osteoporosis.
11:45 - 12:45 p.m. Primary Hyperparathyroidism: New concepts and new guidelines for 2014
John Bilezikian, MD, MACE
Objectives:
  1. Describe the current presentations of primary hyperparathyroidism in the United States and throughout the world.
  2. Summarize new evidence for skeletal involvement.
  3. Present the results of the 4th International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
12:45 - 2:15 p.m. Lunch
2:15 - 3:15 p.m. Renal Effects of SGLT2 Inhibitors
Matthew R. Weir, MD
Objectives:
  1. Appreciate the systemic effects of chemically-induced glycosuria.
  2. Be aware of the effects of SGLT2 inhibitors on blood pressure and body weight.
  3. Be aware of possible side effects associated with osmotic diuresis.
3:15 - 4:15 p.m. Hyperparathyroidism: What we've learned from 23,000 parathyroid operations
James Norman, MD, FACS, FACE
Objectives:
  1. Discuss the appropriate surgical treatment of parathyroid disease.
  2. Recognize that determining severity of parathyroid disease that may be independent of calcium levels.
  3. Discuss the appropriate utilization of imaging tests in managing parathyroid disease.
4:15 - 4:30 p.m. Post Meeting Assessment
Objectives:
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
4:30 p.m. Adjournment
The annual, offsite, family dinner will be held at Emeril's Restaurant, 800 Tchoupitoulas Street, New Orleans. Opened in 1990 by Chef Emeril Lagasse in New Orleans, Emeril's Restaurant serves his signature style of "New New Orleans" cuisine, featuring the best local and regional seasonal ingredients. Emeril's is nestled in a renovated pharmacy warehouse on Tchoupitoulas Street in the heart of the city's Warehouse District. The menu selection will include a fish, seafood or chicken entrée option. Seating is limited to the first 50 registered participants. Adult meals are $50 and children 12 and under $25. Advance registration required.
Sunday, February 9, 2014
7:00 - 8:00 a.m. Continental Breakfast
8:00 - 8:15 a.m. Opening Remarks & Pre-Meeting Assessment
Objectives:
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:15 - 9:15 a.m. An Update on GLP-1/Incretins
Vivian Fonseca, MD, FRCP, FACE
Objectives:
  1. Discuss briefly the history of the evolution of GLP-1 agonist therapy in type 2 diabetes.
  2. Analyze the data of the recent clinical trials as related to:
    • cardiovascular safety
    • pancreatitis/pancreatic cancer
  3. Discuss the new developments in GLP-1 therapy (as related to formulations and in combination with long acting insulins).
  4. Outline potential future therapeutic strategies with GLP-1 agonists.
9:15 - 10:15 a.m. Dopamine Agonists and Prolactinomas: Current controversies
Brooks Vaughn, MD
Objectives:
  1. Recognize current safety concerns regarding medical therapy of prolactinomas.
  2. Analyze the available safety data.
  3. Apply the current guidelines to patients with prolactinomas.
10:15 - 10:45 a.m. Break
10:45 - 11:45 a.m. Androgenic Disorders in Women: Facts & fantasy
Andrea Dunaif, MD
Objectives:
  1. List disorders of increased and decreased androgen production in women.
  2. Explain the diagnosis and treatment of androgen disorders in women.
  3. Explain the limitations of testosterone measurements in women.
11:45 - 12:15 p.m. Difficult Diabetes Cases Panel Discussion
R. Dale Childress, MD, FACE; Jayant Dey, MD, MBBS; Fernando Ovalle, MD, FACE
Objectives:
  1. Consider differential diagnosis of difficult and/or unusual cases of diabetes.
  2. Order appropriate investigations to diagnose difficult and/or unusual cases of diabetes.
  3. Improve the therapeutic approach to difficult and/or unusual cases of diabetes.
12:15 - 12:30 p.m. Post Meeting Assessment
Objectives:
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
12:30 p.m. Adjournment
Southern States Chapter of AACE Annual Meeting
February 7-9, 2014


Location:
Hilton New Orleans Riverside
2 Poydras at the River
New Orleans, LA 70140

Program Committee:
Amna Khan, MD - Program Chair
Michael G. Carlson, MD, FACE
Pavan Chava, DO - SS-AACE President
*Fernando Ovalle, MD, FACE
Richard S. Rosenthal, MD, FACE
Mark D. Shepherd, MD, FACE
Elizabeth Stahl, MD
Lisa Usdan, MD
*indicates both a member of the Program Committee and faculty.

ACCREDITATION STATEMENT
This activity has been approved for AMA PRA Category 1 Credit™.

TARGET AUDIENCE
Endocrinologists and other healthcare professionals in the states of Alabama, Louisiana, Mississippi, and Tennessee.

CORPORATE SUPPORTERS
Corporate supporters will be listed in the program syllabus.

HOTEL ACCOMMODATIONS
To make reservations, contact the Hilton New Orleans Riverside hotel at 800-445-8667. In order to receive the discounted group rate of $179/night, please give the group name or code below. The hotel cutoff date is January 8, 2014.
Group Name: Southern States AACE Annual Meeting
Address: 2 Poydras at the River, New Orleans, LA 70140

DISCLAIMER
The material presented during the Southern States Chapter of AACE annual meeting is being made available by the Southern States Chapter of AACE for educational purposes only, and does not necessarily represent the only or best method or procedure appropriate for the medical situations discussed. The opinions and views expressed represent the opinions of the presenters and not necessarily those of the Southern States Chapter of AACE, AACE, or its governing body. Therefore, the Southern States Chapter of AACE and AACE disclaim any and all liability for injury or other damages resulting to an individual attending this meeting or to any third party for claims based upon the use of techniques and/or products presented by any party at this meeting.

CANCELLATIONS/NO SHOW POLICY
Cancellations received at least two weeks in advance of scheduled activity will be refunded less a 10% processing fee, with a minimum fee of $10. Cancelations received after this date will not be refunded except in extenuating circumstances in which case a request must be made in writing and reviewed by the Chapter President.

Online registration now closed. Onsite registration will be available

AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.